I agree that this site is using cookies. You can find further informations here.
X
Velcheti, V.
46  results:
Search for persons X
?
1

89P Predictors of real-world (rw) outcomes in patients (pts..:

Velcheti, V. ; Sun, X. ; Nguyen, J....
ESMO Open.  9 (2024)  - p. 102668 , 2024
Link: https://doi.org/10.1016/..
 
?
2

50P Radiomic features of both primary lung nodules and lymp..:

Khorrami, M. ; Viswanathan, V.S. ; Mutha, P.J....
ESMO Open.  9 (2024)  - p. 102629 , 2024
Link: https://doi.org/10.1016/..
 
?
3

P1.21-09 Radiomic Signature of Identifies Outcome and Progn..:

Hiremath, A. ; Bera, K. ; Gupta, A....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S237-S238 , 2023
Link: https://doi.org/10.1016/..
 
?
4

OA03.06 Repotrectinib in Patients with ROS1 Fusion-positive..:

Cho, B.C. ; Camidge, D.R. ; Lin, J.J....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S50-S51 , 2023
Link: https://doi.org/10.1016/..
 
?
5

157TiP Krascendo-170 Lung: A phase Ib/II study of divarasib..:

Skoulidis, F. ; Cuppens, K. ; Sacher, A....
Immuno-Oncology and Technology.  20 (2023)  - p. 100668 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Immunotherapy in the first-line treatment of elderly patien..:

Gridelli, C. ; Peters, S. ; Velcheti, V...
ESMO Open.  8 (2023)  2 - p. 101192 , 2023
Link: https://doi.org/10.1016/..
 
?
7

EP12.01-38 Real-world Outcomes in a U.S. Asian Population w..:

Liu, Y. ; Bi, J. ; Moreira, A....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S655-S656 , 2023
Link: https://doi.org/10.1016/..
 
?
8

P2.07-06 Real World Efficacy of First-Line Immunotherapy +/..:

Akerley, W. ; Halawani, H. ; Schaefer, E....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S325 , 2023
Link: https://doi.org/10.1016/..
 
?
9

EE35 Cost-Effectiveness Analysis of Nivolumab Plus Ipilimum..:

Chen, J ; Velcheti, V ; Padula, W
Value in Health.  25 (2022)  7 - p. S342 , 2022
Link: https://doi.org/10.1016/..
 
?
10

P16 Recent Estimates of Survival in Patients with Advanced ..:

Kalilani, L ; Chao, J ; Hogea, C...
Value in Health.  25 (2022)  1 - p. S4 , 2022
Link: https://doi.org/10.1016/..
 
?
11

EP08.01-021 Phase 2 Study Evaluating Inupadenant in Combina..:

SRIVASTAVA, S. ; O'Brien, M. ; Cheema, P.K....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S346-S347 , 2022
Link: https://doi.org/10.1016/..
 
?
12

P1.11-01 Cobolimab with Dostarlimab and Docetaxel in Patien..:

Kim, H.R. ; Gridelli, C. ; Kapur, D....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S109-S110 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Pivotal topline data from the phase 1/2 TRIDENT-1 trial of ..:

Cho, B.C. ; Lin, J. ; Camidge, D.R....
European Journal of Cancer.  174 (2022)  - p. S1-S2 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Cardiovascular adverse events are associated with usage of ..:

Jain, P. ; Gutierrez Bugarin, J. ; Guha, A....
ESMO Open.  6 (2021)  5 - p. 100252 , 2021
Link: https://doi.org/10.1016/..
 
?
15

Corrigendum to 'Cardiovascular adverse events are associate..:

Jain, P. ; Gutierrez Bugarin, J. ; Guha, A....
ESMO Open.  6 (2021)  6 - p. 100286 , 2021
Link: https://doi.org/10.1016/..
 
1-15